Streetbeat News

SOND

Sonder Holdings Inc.

https://www.sonder.com

Industry

Travel Lodging

Sonder Holdings Inc. engages in the hospitality business. It operates and manages properties comprising 1-, 2-, and 3+ bedroom; and studio apartments, as well as 1-bedroom hotel rooms for leisure travelers and families, digital nomads, and professionals in North America, Europe, and the Middle East. As of December 31, 2021, it had approximately 7,600 live units across 38 markets and 10 countries, as well as approximately 10,500 additional contracted units. The company is headquartered in San Francisco, California.

Open

3.67

Mkt cap

37M

Volume

63K

High

3.75

P/E Ratio

-0.20

52-wk high

10.50

Low

3.20

Div yield

N/A

52-wk low

0.88

U.S. stocks rose with the Nasdaq gaining 150 points. ZIM Integrated Shipping Services reported strong Q2 results, boosting its stock. Alzamend Neuro surged 474% after announcing a partnership for a PTSD study. Sonder Holdings rose 98% following a licensing deal with Marriott and securing $146M in liquidity. Liquidia Corporation fell 29% after FDA's tentative approval of YUTREPIA. Theriva Biologics and Cingulate Inc. also saw significant declines.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 6:37 pm

Sonder Holdings' stock surged over 125% following a licensing agreement with Marriott International. The deal will integrate Sonder's apartment-style accommodations into Marriott's system, enhancing Marriott's offerings. Sonder also secured $146 million in new liquidity.

Portfolio Pulse from Dylan Berman

August 19, 2024 | 5:55 pm

Nikola Corporation's shares fell by 10.4% after announcing a securities purchase agreement and a mixed shelf offering. Other stocks like Alzamend Neuro and Virax Biolabs saw significant gains, while Liquidia Corporation and Theriva Biologics experienced notable declines.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 5:37 pm

U.S. stocks rose with the Dow Jones, NASDAQ, and S&P 500 all gaining. Alzamend Neuro shares surged 418% due to a new partnership for a PTSD treatment study. Virax Biolabs shares increased 308% following WHO's virus emergency declaration. Sonder Holdings shares rose 46% after a licensing agreement with Marriott. Liquidia Corporation shares fell 39% after FDA's tentative approval of YUTREPIA. Theriva Biologics shares dropped 29% following a reverse stock split. Cingulate shares decreased 33% after increasing its stock offering price.

Portfolio Pulse from Avi Kapoor

August 19, 2024 | 4:28 pm

Sonder shares have resumed trading, which could indicate a resolution of previous issues that halted trading. Investors should monitor the situation closely for further developments.